KalVista Pharmaceuticals, Inc. Ratios

Ratios Dec2013 Dec2014 Apr2015 Dec2015 Apr2016 Apr2017 Apr2018 Apr2019 Apr2020 Apr2021 Apr2022 Apr2023 Apr2024 Apr2025
Profitability
EBT Margin -1,353.98%-43,989.66%-447.34%-76,617.24%-709.38%-1,236.90%-188.29%-128.31%-230.42%-253.29%3,112.39%
EBIT Margin -1,256.87%-40,265.52%-448.39%-72,537.93%-711.72%-1,485.31%-222.84%-184.91%-319.41%-280.89%3,249.70%
EBITDA Margin -1,256.87%-40,265.52%-409.20%-72,537.93%-641.16%-1,407.65%-170.01%-134.14%-229.09%-254.14%3,200.86%
Operating Margin -1,256.87%-40,265.52%-448.39%-72,537.93%-711.72%-1,485.31%-222.84%-184.91%-319.41%-280.89%3,249.70%
Net Margin -1,353.98%-43,989.66%-510.14%-76,617.24%-725.50%-1,381.32%-188.29%-129.08%-229.44%-253.29%3,171.17%
FCF Margin -1,174.94%-39,351.72%-359.92%-74,213.79%-617.30%-1,582.18%108.78%-232.19%-354.89%-179.26%2,651.72%
Efficiency
Assets Average 40.77M29.55M47.87M89.76M105.33M
Equity Average -38.94M-33.87M12.88M6.10M-2.89M29.29M62.00M90.25M
Invested Capital -33.71M-39.75M-23.55M50.77M-36.98M31.33M27.25M96.74M83.75M206.58M
Asset Utilization Ratio 0.050.050.180.180.12
Leverage & Solvency
Interest Coverage Ratio -12.88-10.79-17.71-32.50
Debt to Equity -0.100.090.00
Debt Ratio 0.670.080.01
Equity Ratio -6.650.87-1.500.910.440.820.910.88
Times Interest Earned -12.88-10.79-17.71-32.50
Valuation
Enterprise Value -9.78M-3.90M114.64M-37.92M-2.49M41.79M40.47M295.88M126.98M606.98M312.44M358.43M268.44M684.58M
Market Capitalization 117.16M15.80M19.28M72.74M91.53M396.69M194.70M606.98M312.44M358.43M478.84M684.58M
Return Ratios
Return on Sales -13.54%-439.90%-4.47%-766.17%-7.09%-12.37%-1.88%-1.29%-2.29%-2.53%31.71%
Return on Capital Employed -0.40%-0.84%-0.76%-0.42%-0.42%
Return on Invested Capital -0.45%
Return on Assets -0.37%-0.63%-0.33%-0.23%-0.28%
Return on Equity 0.33%0.24%-1.73%-2.48%6.43%-0.54%-0.34%-0.32%